Brief: Calavo Growers Q3 Adjusted EPS USD 0.57

Calavo Growers

09/09/2025 21:10

Overview

Calavo Q3 revenue dips to $178.8 mln, misses analysts' expectations, per LSEG data

Adjusted EPS of $0.57 also below estimates, per LSEG data

FDA detention hold on avocados led to $4.2 mln in discrete costs

Outlook

Company projects Prepared segment sales of approximately $115 mln for fiscal 2026

Company sees momentum in Prepared segment with annualized sales over $100 mln

Calavo Growers believes it is well-positioned for future growth

Result Drivers

FDA DETENTION HOLD - Temporary hold on avocado imports led to $4.2 mln in costs, impacting Fresh segment gross profit

FRESH SEGMENT DECLINE - 5% decrease in Fresh segment sales due to lower avocado and tomato volumes

PREPARED SEGMENT GROWTH - 40% increase in Prepared segment sales driven by higher volumes and operational efficiencies

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q3 Revenue
Miss
$178.80 mln
$195.50 mln (3 Analysts)
Q3 Adjusted EPS
Miss
$0.57
$0.59 (3 Analysts)
Q3 Adjusted Net Income
Miss
$10.20 mln
$11.20 mln (2 Analysts)
Q3 Adjusted EBITDA
Miss
$15.10 mln
$17.40 mln (2 Analysts)
Q3 Gross Profit
$18.20 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the food processing peer group is "buy"

Wall Street's median 12-month price target for Calavo Growers Inc is $35.00, about 22.3% above its September 8 closing price of $27.21

The stock recently traded at 14 times the next 12-month earnings vs. a P/E of 14 three months ago

Press Release: ID:nGNX6Jf2xv

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)